[widget id="nav_menu-5"]
[widget id="text-8"][widget id="custom_html-3"]
The following Industry-Supported Symposia, organized by ICNMD 2022 sponsors, were available during the 2022 Live Days. Click on the tabs below to read more.
![]() |
ISS01 Time: 13:00 - 14:00 CEST | Room: Silver Hall, Level 0 Title: Long-term treatment experience in patients with nmDMD Description Join our expert faculty in an interactive, peer-to-peer discussion treatment of patients with nonsense mutation Duchenne muscular dystrophy (nmDMD). Through the use of real-world clinical case studies, the challenges patients face in transitioning from paediatric to adult care will also be discussed, alongside the key outcomes for these patients. Speakers:
For more information, click here. |
![]() |
ISS02
Time: 13:00 – 14:00 (CEST) | Room: Copper Hall, Level 0 Title: Building on Real-world Spinal Muscular Atrophy Gene Therapy Experience to Transform Patient Care Description Symposium Objectives:
Agenda & Speakers:
For more information, click here. |
![]() |
ISS03
Time: 13:00 – 14:00 (CEST) | Room: Studio 211+212, Level +2 Title: Exploring the Treatment Galaxy: AAV-based Gene Transfer Therapies for Patients Living with Neuromuscular Diseases Description Description: Chair: Volker Straub, MD, PhD Speakers:
For more information, click here. |
![]() |
ISS04
Time: 18:00 – 19:00 (CEST) | Room: Copper Hall, Level 0 Title: Intrahepatic Cholestasis in X-Linked Myotubular Myopathy (XLMTM) Description Agenda & Speakers:
For more information, click here. |
![]() |
ISS06
Time: 7:00 – 8:00 (CEST) | Room: Studio 214+216, Level +2 Title: Channelling the myotonia diagnosis Description Description: Discover how prompt, accurate, disease recognition can help patients with myotonic disorders to understand (and reduce the impact of) their symptoms. Agenda & Speakers
For more information, click here. |
![]() |
ISS07
Time: 7:00 – 8:00 (CEST) | Room: Copper Hall, Level 0 Title: Managing Generalised Myasthenia Gravis: A Tale of Two Targets Description Description: The symposium will focus on improving clinicians’:
Agenda & Speakers:
For more information, click here. |
![]() |
ISS08
Time: 13:00 – 14:00 (CEST) | Room: Copper Hall, Level 0 Title: From traditional to targeted: Innovations in the changing gMG landscape Description Description: Agenda & Speakers:
For more information, click here. |
![]() |
ISS09
Time: 13:00 – 14:00 (CEST) | Room: Silver Hall, Level 0 Title: Pompe Disease – How Could We Achieve Better Outcomes for Patients? Description Description: Agenda & Speakers:
For more information, click here. |
![]() |
ISS10
Time: 13:00 – 14:00 (CEST) | Room: Gold Hall, Level 0 Title: Everyday SMA: its daily impact and optimal management from infancy to adulthood Description Symposium objectives:
Agenda:
Speakers:
For more information, click here. |
![]() |
ISS11
Time: 18:00 – 19:00 (CEST) | Room: Copper Hall, Level 0 Title: CIDP: Early treatment escalation in non IVIg responders. Description Description: Speakers:
|
![]() |
ISS12 Time: 18:00 - 19:00 CEST | Room: Silver Hall, Floor 0 Title: Targeting complement to fight chronic burden in gMG Description Description: Agenda & Speakers:
For more information, click here. |
![]() |
ISS13
Time: 7:00 – 8:00 (CEST) | Room: Studio 211+212, Level +2 Title: Measuring Progression in FSHD: Implications for Clinical Trials Description Description: Speakers:
For more information, click here. |
![]() |
ISS14
Time: 7:00 – 8:00 (CEST) | Room: Silver Hall, Level 0 Title: The Maze of Mimics: Can You Identify CIDP? Description Description: Agenda & Speakers:
For more information, click here.
|
![]() |
ISS15
Time: 13:00 – 14:00 (CEST) | Room: Copper Hall, Level 0 Title: Uncovering the missing pieces of the SMA puzzle? Description Description: Learning objectives:
Agenda & Speakers:
For more information, click here. Biogen have funded and organized this event but have had no other involvement in the ICNMD congress agenda. The content for this symposium was approved by the Scientific Program Committee as an independent activity held in conjunction with the 17th International Congress on Neuromuscular Diseases. This symposium is not sponsored or endorsed by ICNMD 2022. Biogen’s treatment for 5q SMA will be discussed, alongside other treatments for 5q SMA. The Summary of Product Characteristics for its product will be available on request from Biogen staff at the event. Biogen-164071 May 2022 |
![]() |
ISS16
Time: 13:00 – 14:00 (CEST) | Room: Silver Hall, Level 0 Title: Navigating success in ALS: Pathophysiological pathways, the patient journey, and treatment landscape Description Description: Speakers:
For more information, click here. |
![]() |
ISS17
Time: 13:00 – 14:00 (CEST) | Room: Studio 211+212, Level +2 Title:Optimising the care of individuals with DMD in gene therapy clinical trials: learnings from caregivers, PAGs and previous trial experience Description Objectives:
Agenda:
Speakers:
For more information, click here. |